The impact of an antimicrobial cycling strategy for febrile neutropenia in a haematology unit

Journal of Chemotherapy

Volumn 25, Issue 5, 2013, Pages 279-285

  Kontopidou, Flora V ^a   Antoniadou, Anastasia ^b   Tsirigotis, Panagiotis ^b   Venetis, Evangelos ^c   Polemis, Michael ^d   Patrinos, Stavros ^a   Giamarellou, Helen ^e  

^a Hellenic Center for Disease Control and Prevention   (Greece)

^b NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

^c 1st IKA Hospital   (Greece)

^d NATIONAL SCHOOL OF PUBLIC HEALTH   (Greece)

^e IASO GENERAL HOSPITAL   (Greece)

Author keywords

Antibiotic cycling; Antibiotic policy; Antibiotic rotation; Antibiotic strategy; Antimicrobial resistance; Febrile neutropenia; Haematology unit

Indexed keywords

AMIKACIN; ANTIINFECTIVE AGENT; CEFEPIME; CEFTAZIDIME; IMIPENEM; PIPERACILLIN PLUS TAZOBACTAM;

ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL COLONIZATION; CLINICAL ARTICLE; DISEASE SURVEILLANCE; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ESCHERICHIA COLI; FEBRILE NEUTROPENIA; FEMALE; GRAM NEGATIVE INFECTION; GRAM POSITIVE INFECTION; HEMATOLOGY; HUMAN; KLEBSIELLA OXYTOCA; MALE; MULTIPLE CYCLE TREATMENT; PATIENT COMPLIANCE; PNEUMOCYSTIS PNEUMONIA; PROSPECTIVE STUDY; PSEUDOMONAS AERUGINOSA;

ANTI-INFECTIVE AGENTS; DRUG RESISTANCE; FEBRILE NEUTROPENIA; FEMALE; GRAM-NEGATIVE BACTERIA; GRAM-NEGATIVE BACTERIAL INFECTIONS; GRAM-POSITIVE BACTERIA; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES;

EID: 84884780250     PISSN: 1120009X     EISSN: 19739478     Source Type: Journal    
DOI: 10.1179/1973947813Y.0000000077     Document Type: Article

References (22)

1. Freifeld AG, Bow EJ, Sepkowitz KA, Boeckh MJ, Ito JI, Mullen CA, et al. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 Update by the Infectious Diseases Society of America. Clin Infect Dis. 2011;52:e56-93.
2. Viscoli C, Castagnola E. Planned progressive antimicrobial therapy in neutropenic patients. Br J Haematol. 1998;102:879-88.
3. Kollef MH. Inadequate antimicrobial treatment: an important determinant of outcome for hospitalized patients. Clin Infect Dis. 2000;31:S131-8.
4. Giamarellou H. Multidrug-resistant Gram-negative bacteria: how to treat and for how long. Int J Antimicrob Agents. 2010;36:S50-4.
5. Kollef MH. Is there a role for antibiotic cycling in the intensive care unit? Crit Care Med. 2001;29:S135-42.
6. Kollef MH, Fraser VJ. Antibiotic resistance in the intensive care unit. Ann Intern Med. 2001;134:298-314.
7. Pugol M, Gudiol F. Evidence for antibiotic cycling in control of resistance. Curr Opin Infect Dis. 2001;14:711-5.
8. Kollef M. Is antibiotic cycling the answer to preventing the emergence of bacterial resistance in the intensive care unit? Clin Infect Dis. 2006;43:S82-8.
9. Dominguez EA, Smith TL, Reed E, Sanders CC, Sanders WE Jr. A pilot study of antibiotic cycling in a hematology-oncology unit. Infect Control Hosp Epidemiol.2000;21:S4-8.
10. Cadena J, Taboada CA, Burgess DS, Ma JZ, Lewis II JS, Freytes CO, et al. Antibiotic cycling to decrease bacterial antibiotic resistance: a 5-year experience on a bone marrow transplant unit. Bone Marrow Transplant. 2007;40:151-5.
11. Graig M, Cumpston AD, Hobbs GR, De Vetten MP, Sarwari AR, Ericson SG. The clinical impact of antibacterial prophylaxis and cycling antibiotics for febrile neutropenia in a haematological malignancy and transplantation unit. Bone Marrow Transplant. 2007;39:477-82.
12. Hashino S, Morita L, Kanamori H, Takahata M, Onozawa M, Nakagawa M, et al. Clinical impact of cycling the administration of antibiotics for febrile neutropenia in Japanese patients with hematological malignancy. Eur J Clin Microbiol Infect Dis. 2012;31:173-8.
13. Hughes WT, Armstrong D, Bodey GP, Bow EJ, Brown AE, Calandra T, et al. Guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clin Infect Dis. 2002; 34:730-51.
14. Poulakou G, Plachouras D, Kontopidou F, Antoniadou A, Papadomichelakis E, Armaganidis A, et al. Rapid surveillance of multidrug resistance in ICU patients by use of antibiotic containing agar plates. Clin Microbiol Infect. 2008;14:S609-10.
15. Gerding DN. Antimicrobial cycling: lessons learned from the aminoglygoside exrerience. Infect Control Hosp Epidemiol. 2000;21:S2-7.
16. Gruson D, Hilbert G, Vargas F, Valentino R, Bui N, Pereyre S, et al. Strategy of antibiotic rotation: long-term effect on incidence and susceptibilities of Gram-negative bacilli responsible for ventilator-associated pneumonia. Crit Care Med. 2003;31:1908-14.
17. Hughes MG, Evans HL, Chong TW, Smith RL, Raymond DP, Pelletier SJ, et al. Effect of an intensive care unit rotating empiric antibiotic schedule on the development of hospitalacquired infections on the non-intensive care unit ward. Crit Care Med. 2004;32:53-60.
18. Toltzis P, Dul MJ, Hoyen C, Salvator A, Walsh M, Zetts L, et al. The effect of antibiotic rotation on colonization with antibiotic-resistant bacilli in a neonatal intensive care unit. Pediatrics. 2002;110:707-11.
19. Moss WJ, Beers MC, Johnson E, Nichols DG, Perl TM, Dick JD, et al. Pilot study of antibiotic cycling in a pediatric intensive care unit. Critical Care Med. 2002;30:1877-82.
20. Marti{dotless}́nez JA, Nicolás JM, Marco F, Horcajada JP, Garcia-Segarra G, Trilla A, et al. Comparison of antimicrobial cycling and mixing strategies in two medical intensive care units. Crit Care Med. 2006;34:329-36.
21. Raymond DP, Pelletier SJ, Crabtree TD, Gleason TG, Hamm LL, Pruett TL, et al. Impact of a rotating empiric antibiotic schedule on infectious mortality in an intensive care unit. Crit Care Med. 2001;29:1101-8.
22. Merz LR, Warren DK, Kollef MH, Fridkin SK, Fraser VJ. The impact of an antibiotic cycling program on empirical therapy for gram-negative infections. Chest. 2006;130:1672-8.